Overview
- 46 inspections across 41 sites are on record.
- 161 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
46
Sites
41
Observations
161
Career since
Jan 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 27 Mar 2026 | Human Drugs | On file |
| CoreRX Inc. | 26 Feb 2026 | Human Drugs | On file |
| Hit Promotional Products Inc. | 28 Jan 2026 | Human Drugs | On file |
| QOL Medical LLC | 9 Jan 2026 | Human Drugs | On file |
| Actavis Laboratories FL, Inc. | 18 Nov 2025 | Human Drugs | On file |
Sites inspected
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
CoreRX Inc.Clearwater, United States1 insp.
Hit Promotional Products Inc.Saint Petersburg, United States1 insp.
QOL Medical LLCClearwater, United States1 insp.
Actavis Laboratories FL, Inc.Davie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joanne E King6 shared
Saundrea A Munroe4 shared
Jennifer Lalama4 shared
Jessica P Mcalister3 shared
Tammy T Brown2 shared
Nicole E Knowlton2 shared
Suzanne N Vallez2 shared
Lillian M Colon-Mcknight2 shared
Hirdesh Kumar1 shared
Michael Z Weigman1 shared
Full investigator report
Get the verbatim findings behind Kayla V Sprague's 161 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site